Luxembourg Institute of Health

Efficacy of VAL-083 in primary and recurrent brain tumor biopsies. VAL-083 showed consistent and superior anti-tumor activity against MGMT-unmethylated tumors in comparison to temozolomide

AACR Annual Meeting 2019

Dianhydrogalactitol (VAL-083) reduces glioblastoma tumor growth upon bevacizumab-induced hypoxia, in vivo